3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
138
Neoplasms
5
Neoplasm Metastasis
4
Prostate Adenocarcinoma
3
Recurrence
2
Osteoporosis
2
Advanced Prostate Cancer
2
Stage I Prostate Adenocarcinoma AJCC v7
1
Sexual Dysfunction, Physiological
1
Sarcopenia
1
Radiation Injuries
1
Primary Dysautonomias
1
Patients With T1-4 Advanced Prostate Cancer
1
PSA Level Greater Than Two
1
Lymphatic Metastasis
1
Kidney Diseases
1
Hypertension
1
Hot Flashes
1
Hormone Sensitive Prostate Cancer
1
Castration-resistant Prostate Cancer Patients with Oligometastases
1
Castrate Sensitive Prostate Cancer
1
Anemia
1
Interventions
Nutrition Assessment
2
pazopanib
1
enzalutamide
1
bicalutamide
1
Vitamin D
1
Resistance Training
1
Receptors, Androgen
1
Polymorphism, Genetic
1
Palliative Care
1
Lysine Acetyltransferase 5
1
Leuprolide
1
Goserelin
1
Flutamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hypertension
×
Goserelin
×
Genitourinary
×
Clear all
NCT05700903
2026-03-02
ARCH
University of Colorado, Denver
Phase 4
Completed
10 enrolled